We hope you’re looking forward to the EEMGS New Investigators’ HalloweeN! event next Thursday, 28th October, 6.30pm CET!
First we will gain tips and tricks for academic writing from Dr TJ Moore, followed by a chance to get to know each other at our GeNIus Pub Quiz.
To find more details on the event and to register please follow the link!
Join us if you dare, we’re looking forward to seeing you there!
P.s. Costumes are not compulsory but more than welcome!
Working from home? Keep up to date with the latest sequencing technology for mutation detection by joining a webinar on Thursday March 26th on Duplex Sequencing. To register, click here.
Title: Duplex Sequencing™ Technology: Transforming Safety Testing
Date: Thursday, March 26, 2020
Time: 11:00 AM Eastern Daylight Time
Duration: 1 hour
Speakers:
Bob Young, MS
Program Consultant and Study Director, In Vivo Mutation
Merck KGaA, Darmstadt, Germany
Jesse Salk, MD, PhD
CEL, CSO and Founder
TwinStrand Biosciences
In this webinar, you will learn about:
Detailed description:
Duplex Sequencing™ technology is a new error-corrected NGS method that improves sequencing accuracy 100,000-fold. This increase in accuracy opens the door to significant reductions in time spent in drug development, allowing measurement of a compound’s carcinogenic risk months or even years earlier than current methods. DS technology now permits early measurement of ultra-rare new mutants. We will discuss the technology, clinical applications and then explore nonclinical safety assessment applications. Mouse and rat mutation data will be presented from various mutagens, tissues and genes. Mutant frequency data and mutational “fingerprint” data will be discussed in context of human tumors. Plans for collaborative qualification through the HESI Genetic Toxicology Technical Committee will be discussed.
Recent Comments